Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[GS010]----1件: 302 💬
2[NA]----34件: 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
3Béfizal----1件: 302 💬
4Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
5Genetic: GS010----1件: 302 💬
6Genetic: GS010 High dose----1件: 302 💬
7Genetic: GS010 Low dose----1件: 302 💬
8Genetic: IEM-EP----1件: 302 💬
9Genetic: rAAV2-ND4----1件: 302 💬
10Glycerol Tributyrate----2件: 21, 302 💬
11GS010----1件: 302 💬
12Idebenone1件: Idebenone1件: Idebenone 💬 --9件: 6, 8, 13, 17, 18, 21, 113, 115, 302 💬
13Injection needle----1件: 302 💬
14KH1761件: Sonlicromanol---2件: 21, 302 💬
15Lenadogene nolparvovec1件: Lenadogene nolparvovec---1件: 302 💬
16Mecobalamin1件: Mecobalamin1件: Mecobalamin 💬 --3件: 2, 70, 302 💬
17NADH1件: NADH---1件: 302 💬
18NFS-021件: NFS-02---1件: 302 💬
19NFS-02 Injection1件: NFS-02---1件: 302 💬
20Nicotinamide1件: Nicotinamide1件: Niacinamide 💬 --19件: 2, 5, 6, 7, 8, 17, 18, 21, 46, 49, 60, 63, 65, 85, 97, 107, 162, 191, 302 💬
21Nicotinamide treatment1件: Nicotinamide1件: Niacinamide 💬 --2件: 21, 302 💬
22NR082 Injection----1件: 302 💬
23Other: Sham (No Treatment)----1件: 302 💬
24Other: Sham Intravitreal Injection----1件: 302 💬
25Pending----7件: 6, 13, 19, 96, 97, 113, 302 💬
26RAAV2-ND4----1件: 302 💬
27RAAV2/2-ND4 VECTOR----1件: 302 💬
28Raxone----2件: 113, 302 💬
29Recombinant AAV vector serotype 2 containing the human wild type mitochondrial ND4 gene----1件: 302 💬
30Recombinant AAV vector serotype 2 containing the human wild typemitochondrial ND4 gene----1件: 302 💬
31Recombinant Adeno-Associated Viral vector, serotype 2 (rAAV2/2) containing the human wild-type mitochondrial NADH Dehydrogenase 4 gene (ND4)1件: NADH---1件: 302 💬
32Sham Injection----2件: 90, 302 💬
33TAUROURSODEOXYCHOLIC ACID1件: Tauroursodeoxycholic acid1件: Taurursodiol 💬 --5件: 2, 28, 93, 299, 302 💬